Stay updated on Niraparib vs Placebo in HER2- BRCAmut/TNBC Clinical Trial
Sign up to get notified when there's something new on the Niraparib vs Placebo in HER2- BRCAmut/TNBC Clinical Trial page.

Latest updates to the Niraparib vs Placebo in HER2- BRCAmut/TNBC Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedIn the page history, Revision: v3.3.3 was added, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision history shows the addition of Revision v3.3.2 and removal of Revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the government funding operating status notice from the page, a change that affects only site-wide messaging rather than the study record history or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check75 days agoChange DetectedThe latest version updates the Study Status, Study Design, Outcome Measures, and Contacts/Locations on the record page. This reflects updated trial details and current status of the study.SummaryDifference0.1%

- Check103 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference11%

Stay in the know with updates to Niraparib vs Placebo in HER2- BRCAmut/TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib vs Placebo in HER2- BRCAmut/TNBC Clinical Trial page.